Compare EVO & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | MSEX |
|---|---|---|
| Founded | 1993 | 1897 |
| Country | Germany | United States |
| Employees | 4553 | 395 |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 1.0B |
| IPO Year | N/A | N/A |
| Metric | EVO | MSEX |
|---|---|---|
| Price | $2.68 | $50.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $61.33 |
| AVG Volume (30 Days) | 94.1K | ★ 106.2K |
| Earning Date | 04-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | $10.60 |
| Revenue Next Year | $10.05 | $10.94 |
| P/E Ratio | ★ N/A | $22.68 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $44.94 |
| 52 Week High | $4.80 | $62.18 |
| Indicator | EVO | MSEX |
|---|---|---|
| Relative Strength Index (RSI) | 36.25 | 39.55 |
| Support Level | $2.32 | $49.92 |
| Resistance Level | $3.78 | $54.71 |
| Average True Range (ATR) | 0.09 | 1.27 |
| MACD | -0.06 | -0.06 |
| Stochastic Oscillator | 6.44 | 7.85 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.